Restructuring events
European Restructuring Monitor (ERM)
The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
The Dutch pharmaceutical company MSD is restructuring. It is announced that 200 jobs will be cut and that 295 jobs will be relocated following MSD’s sale of its factory in Oss.
The sale of the factory, which produced immunotherapy, is a result of MSD’s plan to focus on production locations outside the Netherlands. According to the company, these production locations together have the sufficient capacity to fulfil the demand for MSD’s immunotherapy.
As of October 2024, it is unknown how the restructuring will proceed or when it will end. It is also unknown which unit is affected the most by the job reduction. However, it is known that 120 office jobs will remain in Oss.
Eurofound (2024), MSD, Offshoring/Delocalisation in Netherlands, factsheet number 201688, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/201688.